BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28864833)

  • 1. Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer.
    Tsukioka T; Izumi N; Mizuguchi S; Kyukwang C; Komatsu H; Toda M; Hara K; Miyamoto H; Nishiyama N
    Int J Clin Oncol; 2018 Feb; 23(1):66-72. PubMed ID: 28864833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancer.
    Komatsu H; Izumi N; Tsukioka T; Inoue H; Hara K; Miyamoto H; Nishiyama N
    Surg Today; 2019 Apr; 49(4):343-349. PubMed ID: 30417262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
    Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
    Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
    Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
    Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.
    Gajra A; Newman N; Gamble GP; Abraham NZ; Kohman LJ; Graziano SL
    Lung Cancer; 2003 Oct; 42(1):51-7. PubMed ID: 14512187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
    Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
    Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
    Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
    Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer.
    Maurizi G; D'Andrilli A; Ciccone AM; Ibrahim M; Andreetti C; Tierno S; Poggi C; Menna C; Venuta F; Rendina EA
    Ann Thorac Surg; 2015 Sep; 100(3):918-24; discussion 924-5. PubMed ID: 26209486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
    Liu T; Liu H; Li Y
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.